Ali S. Saber Tehrani
Johns Hopkins University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ali S. Saber Tehrani.
BMJ Quality & Safety | 2013
Ali S. Saber Tehrani; Hee Won Lee; Simon C. Mathews; Andrew D. Shore; Martin A. Makary; Peter J. Pronovost; David E. Newman-Toker
Background We sought to characterise the frequency, health outcomes and economic consequences of diagnostic errors in the USA through analysis of closed, paid malpractice claims. Methods We analysed diagnosis-related claims from the National Practitioner Data Bank (1986–2010). We describe error type, outcome severity and payments (in 2011 US dollars), comparing diagnostic errors to other malpractice allegation groups and inpatient to outpatient within diagnostic errors. Results We analysed 350 706 paid claims. Diagnostic errors (n=100 249) were the leading type (28.6%) and accounted for the highest proportion of total payments (35.2%). The most frequent outcomes were death, significant permanent injury, major permanent injury and minor permanent injury. Diagnostic errors more often resulted in death than other allegation groups (40.9% vs 23.9%, p<0.001) and were the leading cause of claims-associated death and disability. More diagnostic error claims were outpatient than inpatient (68.8% vs 31.2%, p<0.001), but inpatient diagnostic errors were more likely to be lethal (48.4% vs 36.9%, p<0.001). The inflation-adjusted, 25-year sum of diagnosis-related payments was US
Stroke | 2013
David E. Newman-Toker; Ali S. Saber Tehrani; Georgios Mantokoudis; John H. Pula; Cynthia I. Guede; Kevin A. Kerber; Ari M. Blitz; Sarah H. Ying; Yu Hsiang Hsieh; Richard E. Rothman; Daniel F. Hanley; David S. Zee; Jorge C. Kattah
38.8 billion (mean per-claim payout US
Academic Emergency Medicine | 2013
Ali S. Saber Tehrani; Diarmuid Coughlan; Yu Hsiang Hsieh; Georgios Mantokoudis; Fredrick K. Korley; Kevin A. Kerber; Kevin D. Frick; David E. Newman-Toker
386 849; median US
Neurology | 2014
Ali S. Saber Tehrani; Jorge C. Kattah; Georgios Mantokoudis; John H. Pula; Deepak Nair; Ari M. Blitz; Sarah Ying; Daniel F. Hanley; David S. Zee; David E. Newman-Toker
213 250; IQR US
Otology & Neurotology | 2015
Georgios Mantokoudis; Ali S. Saber Tehrani; Amy W. Wozniak; Karin Eibenberger; Jorge C. Kattah; Cynthia I. Guede; David S. Zee; David E. Newman-Toker
74 545–484 500). Per-claim payments for permanent, serious morbidity that was ‘quadriplegic, brain damage, lifelong care’ (4.5%; mean US
Audiology and Neuro-otology | 2015
Georgios Mantokoudis; Ali S. Saber Tehrani; Jorge C. Kattah; Karin Eibenberger; Cynthia I. Guede; David S. Zee; David E. Newman-Toker
808 591; median US
Otology & Neurotology | 2014
Georgios Mantokoudis; Michael C. Schubert; Ali S. Saber Tehrani; Aaron L. Wong; Yuri Agrawal
564 300), ‘major’ (13.3%; mean US
Neurology: Clinical Practice | 2013
Jorge C. Kattah; Sara S. Dhanani; John H. Pula; Georgios Mantokoudis; Ali S. Saber Tehrani; David E Newman Toker
568 599; median US
Neurology | 2014
Shin C. Beh; Ali S. Saber Tehrani; Amir Kheradmand; David S. Zee
355 350), or ‘significant’ (16.9%; mean US
Journal of Neuro-ophthalmology | 2016
Simon Cardenas-Robledo; Ali S. Saber Tehrani; Gregory Blume; Jorge C. Kattah
419 711; median US